A biotechnology company focused on developing antibody-drug conjugate (ADC) therapies for cancer. Its lead products and pipeline target ovarian and other solid tumors by combining tumor‑targeting antibodies with potent cell‑killing agents. Investors track the firm for clinical trial results, regulat...
1 member of Congress has disclosed 2 trades in ImmunoGen, Inc. (IMGN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-01-09 | Thomas MacArthur | buy | $1K – $15K |
| 2016-12-08 | Thomas MacArthur | sell | $1K – $15K |